Abstacts and Posters Archives - Xilis Informed Choices. Better Outcomes. Wed, 14 Jun 2023 11:42:29 +0000 en-US hourly 1 https://wordpress.org/?v=6.7 https://xilis.com/wp-content/uploads/2021/05/cropped-favLogo-150x150.png Abstacts and Posters Archives - Xilis 32 32 Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer (MODEL-ABC) https://xilis.com/news/pilot-study-of-a-micro-organosphere-drug-screen-platform-to-lead-care-in-advanced-breast-cancer-model-abc/ Wed, 14 Jun 2023 09:41:05 +0000 https://xilis.com/?post_type=news&p=1756 The post Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer (MODEL-ABC) appeared first on Xilis.

]]>
The post Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer (MODEL-ABC) appeared first on Xilis.

]]>
MicroOrganoSpheres as a Clinically Applicable Precision Oncology Platform for the Discovery of Novel Therapies in Colorectal Cancer https://xilis.com/news/microorganospheres-as-a-clinically-applicable-precision-oncology-platform-for-the-discovery-of-novel-therapies-in-colorectal-cancer/ Fri, 09 Jun 2023 09:36:52 +0000 https://xilis.com/?post_type=news&p=1752 The post MicroOrganoSpheres as a Clinically Applicable Precision Oncology Platform for the Discovery of Novel Therapies in Colorectal Cancer appeared first on Xilis.

]]>
The post MicroOrganoSpheres as a Clinically Applicable Precision Oncology Platform for the Discovery of Novel Therapies in Colorectal Cancer appeared first on Xilis.

]]>
Patient-derived MicroOrganoSpheres (MOS)TM and clinical response to immunotherapy https://xilis.com/news/patient-derived-microorganospheres-mostm-and-clinical-response-to-immunotherapy/ Fri, 09 Jun 2023 09:34:20 +0000 https://xilis.com/?post_type=news&p=1748 The post Patient-derived MicroOrganoSpheres (MOS)<sup>TM</sup> and clinical response to immunotherapy appeared first on Xilis.

]]>
The post Patient-derived MicroOrganoSpheres (MOS)<sup>TM</sup> and clinical response to immunotherapy appeared first on Xilis.

]]>
Patient-derived MicroOrganoSpheres (MOS)TM enable precision clinical decision-making for multiple myeloma patients https://xilis.com/news/patient-derived-microorganospheres-mostm-enable-precision-clinical-decision-making-for-multiple-myeloma-patients-2/ Fri, 09 Jun 2023 09:27:45 +0000 https://xilis.com/?post_type=news&p=1744 The post Patient-derived MicroOrganoSpheres (MOS)<sup>TM</sup> enable precision clinical decision-making for multiple myeloma patients appeared first on Xilis.

]]>
The post Patient-derived MicroOrganoSpheres (MOS)<sup>TM</sup> enable precision clinical decision-making for multiple myeloma patients appeared first on Xilis.

]]>
A novel and rapid patient-derived organoid breast cancer platform for precision medicine https://xilis.com/news/a-novel-and-rapid-patient-derived-organoid-breast-cancer-platform-for-precision-medicine/ Fri, 21 Apr 2023 07:38:29 +0000 https://xilis.com/?post_type=news&p=1696 The post A novel and rapid patient-derived organoid breast cancer platform for precision medicine appeared first on Xilis.

]]>
The post A novel and rapid patient-derived organoid breast cancer platform for precision medicine appeared first on Xilis.

]]>
Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS)TM enables correlation of targeted therapy combination response with clinical outcomes https://xilis.com/news/refractory-colorectal-cancer-patient-derived-microorganospheres-mostm-enables-correlation-of-targeted-therapy-combination-response-with-clinical-outcomes/ Fri, 21 Apr 2023 07:35:15 +0000 https://xilis.com/?post_type=news&p=1692 The post Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS)<sup>TM</sup> enables correlation of targeted therapy combination response with clinical outcomes appeared first on Xilis.

]]>
The post Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS)<sup>TM</sup> enables correlation of targeted therapy combination response with clinical outcomes appeared first on Xilis.

]]>
Patient-derived MicroOrganoSpheres (MOS)TM enable precision clinical decision-making for multiple myeloma patients https://xilis.com/news/patient-derived-microorganospheres-mostm-enable-precision-clinical-decision-making-for-multiple-myeloma-patients/ Thu, 20 Apr 2023 07:30:30 +0000 https://xilis.com/?post_type=news&p=1688 The post Patient-derived MicroOrganoSpheres (MOS)<sup>TM</sup> enable precision clinical decision-making for multiple myeloma patients appeared first on Xilis.

]]>
The post Patient-derived MicroOrganoSpheres (MOS)<sup>TM</sup> enable precision clinical decision-making for multiple myeloma patients appeared first on Xilis.

]]>
Feasibility of establishing and drug screening patient-derived rectal organoid models from pretreatment rectal cancer biopsies https://xilis.com/news/feasibility-of-establishing-and-drug-screening-patient-derived-rectal-organoid-models-from-pretreatment-rectal-cancer-biopsies/ Thu, 19 Jan 2023 09:11:40 +0000 https://xilis.com/?post_type=news&p=1709 The post Feasibility of establishing and drug screening patient-derived rectal organoid models from pretreatment rectal cancer biopsies appeared first on Xilis.

]]>
The post Feasibility of establishing and drug screening patient-derived rectal organoid models from pretreatment rectal cancer biopsies appeared first on Xilis.

]]>
Micro-OrganoSpheresTM as a Novel Precision Oncology Platform in Colorectal Cancer https://xilis.com/news/micro-organospherestm-as-a-novel-precision-oncology-platform-in-colorectal-cancer/ Wed, 01 Sep 2021 09:15:13 +0000 https://xilis.com/?post_type=news&p=1714 The post Micro-OrganoSpheres<sup>TM</sup> as a Novel Precision Oncology Platform in Colorectal Cancer appeared first on Xilis.

]]>
The post Micro-OrganoSpheres<sup>TM</sup> as a Novel Precision Oncology Platform in Colorectal Cancer appeared first on Xilis.

]]>
Micro-organospheres: An Automated Platform for Repid Drug Screening in Patient-Derived Breast Cancer Organoids https://xilis.com/news/micro-organospheres-an-automated-platform-for-repid-drug-screening-in-patient-derived-breast-cancer-organoids/ Wed, 01 Sep 2021 09:00:58 +0000 https://xilis.com/?post_type=news&p=1718 The post Micro-organospheres: An Automated Platform for Repid Drug Screening in Patient-Derived Breast Cancer Organoids appeared first on Xilis.

]]>
The post Micro-organospheres: An Automated Platform for Repid Drug Screening in Patient-Derived Breast Cancer Organoids appeared first on Xilis.

]]>